The predictive value of early changes in 18F-fluoroestradiol PET/CT during fulvestrant 500 mg therapy in patients with ER-positive metastatic breast cancer

Authors :: C. Liu
Zhimin Shao
Z.-Y. Yang
G.-Y. Liu
M. He
Y.-J. Zhang
Zhe Wang
Source :: The Breast. 44:S58
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
medicine.medical_specialty
PET-CT
Fulvestrant
business.industry
General Medicine
medicine.disease
Metastatic breast cancer
Predictive value
Internal medicine
Medicine
Surgery
In patient
business
medicine.drug

Full Text Access

Tools